Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients
- 245 Downloads
Goal of work
This study was performed to evaluate the clinical features and outcomes of Staphylococcus aureus infection in non-neutropenic cancer patients.
Materials and methods
From the database of a surveillance study for S. aureus infections, the data regarding S. aureus infections in non-neutropenic cancer patients were analyzed.
Of 649 non-neutropenic cancer patients with S. aureus infections, 156 (24.0%) had a central venous catheter and 176 (27.1%) had an indwelling urinary catheter. The prevalence of methicillin-resistant S. aureus (MRSA) infections was 54.7% (355 out of 649). As for types of infection, skin and soft tissue infections were the most common (n = 173, 26.7%), followed by pneumonia (n = 165, 25.4%) and primary bacteremia (n = 91; 14.0%). Overall, the 30-day mortality rate was 28.2% (124 out of 440), 34.1% (73 out of 214) in MRSA group, and 22.6% (51 out of 226) in methicillin-sensitive S. aureus group (P = 0.007). When outcomes according to the types of infection were evaluated, the mortality rates were 49.5% (53 out of 107) for pneumonia and 41.2% (49 out of 119) for bacteremia. Multivariate analysis showed that pneumonia, concomitant bacteremia, comorbid liver disease, and intubated state with ICU care were independent risk factors associated with 30-day mortality.
Our study demonstrated that S. aureus infections in cancer patients are serious clinical conditions with high mortality rates, even in non-neutropenic patients.
KeywordsStaphylococcus aureus Risk factors Treatment outcome Infection Neoplasms
The authors would like to thank all investigators of the ANSORP study group who participated in this study. This study was financially supported by the Asia Pacific Foundation for Infectious Diseases (Seoul, South Korea).
Potential conflicts of interest
No conflicts for all authors.
- 4.Stryjewski ME, Kanafani ZA, Chu VH, Pappas PA, Harding T, Drew LA, Benjamin DK Jr, Reller LB, Lee BA, Corey GR, Fowler VG Jr (2009) Staphylococcus aureus bacteremia among patients with health care-associated fever. Am J Med 122(281–289):e282Google Scholar
- 11.Song JH, Hsueh PR, Ko KS, Kang CI, Chung DR (2008) Nosocomial origin of community-associated methicillin-resistant Staphylococcus aureus in Asian countries: an ANSORP surveillance study. In: 48th annual ICAAC/IDSA 46th annual meeting, Washington, 25–28 October 2008, p 152Google Scholar
- 12.Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Kim SW, Chang HH, Kim YS, Jung SI, Son JS, Hsueh PR, So TM, Lalitha MK, Yang Y, Huang SG, Wang H, Lu Q, Carlos CC, Perera JA, Chiu CH, Liu JW, Chongthaleong A, Thamlikitkul V, Van Pham H (2010) Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect 61:299–306PubMedCrossRefGoogle Scholar
- 14.Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797PubMedGoogle Scholar